Riskpilot← Back to searchSign inGet full accessPlomedics AB
ABActiveOrg 5567640833Brunnsgatan 14 DGeneral medical practice activities · NACE 8621Est. 20080 employees
Revenue 2025
SEK 0
EBITDA margin
—
+55% vs 2024
Equity ratio
91.0%
Financial strength
Net profit 2025
SEK 37K
-42% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | +55% |
| Net profit | SEK 37K | -42% |
| Total assets | SEK 4M | -5% |
| Equity | SEK 3,6M | -5% |
| Employees | 0 | — |
Legal name
Plomedics AB
Org number
5567640833
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 augusti 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva sjukvård, utbildning, medicinsk utveckling, handel med medicinska produkter, värdepappersförvaltning och därmed förenlig verksamhet.
Address
Brunnsgatan 14 D
Email
annaradingploman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 3 787 | 3 854 | 3 873 | 3 870 | 3 231 | 2 802 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 697 | 1 691 | 1 793 | 1 433 | 1 591 | 1 860 | 1 978 | 1 960 | 1 306 | −29 | −13 |
| Depreciation & amort. | −450 | −460 | −542 | −540 | −524 | −529 | −200 | −42 | −133 | −0 | −0 |
| EBIT | 1 247 | 1 231 | 1 251 | 893 | 1 067 | 1 331 | 1 778 | 1 918 | 1 173 | −29 | −13 |
| Net financials | −75 | −32 | −28 | −1 | — | −1 | — | 8 | 81 | 111 | 61 |
| Profit before tax | 1 173 | 1 199 | 1 223 | 892 | 1 068 | 1 330 | 1 778 | 1 926 | 943 | 82 | 48 |
| Tax | −260 | −265 | −272 | −201 | −233 | −289 | −367 | −392 | −195 | −18 | −11 |
| Net profit | 913 | 934 | 951 | 691 | 835 | 1 041 | 1 411 | 1 534 | 748 | 64 | 37 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 881 | 3 530 | 4 204 | 4 524 | 5 389 | 5 096 | 4 105 | 5 629 | 4 363 | 4 159 | 3 950 |
| Equity | 1 250 | 1 035 | 1 056 | 932 | 1 191 | 1 622 | 2 408 | 3 367 | 3 915 | 3 779 | 3 596 |
| Long-term debt | 788 | 1 924 | 2 863 | 3 356 | 3 929 | 3 175 | 1 257 | 1 857 | 44 | 37 | 0 |
| Short-term debt | 843 | 571 | 285 | 236 | 269 | 298 | 439 | 405 | 89 | 28 | 39 |
| Total debt | 1 631 | 2 495 | 3 148 | 3 592 | 4 198 | 3 473 | 1 696 | 2 262 | 133 | 65 | 39 |
EBITDA margin
-1300000.0%
This company
15.8%
Market median
-8227948% vs market
20152025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20152025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20152025
Net profit margin
3700000.0%
This company
8.1%
Market median
+45678912% vs market
20152025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MA | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Plomedics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Ploman | Chief Executive Officer | 0 companies |
| Mats Anders Gyllenberg | Audit | 0 companies |
| Anna Helena Rading Ploman | Deputy Board Member | 0 companies |